Terra Tech Corp. (TRTC) Financials Nov 18, 2014, 5:20

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Terra Tech Corp. (TRTC) Financials Nov 18, 2014, 5:20 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Terra Tech Corp.


Fiscal year is January-December. All values USD millions. 2012 2013 5-year trend
Sales/Revenue - - - 552,579 2.13M
Cost of Goods Sold (COGS) incl. D&A - - - 451,713 2.04M
COGS excluding D&A - - - 437,625 2M
Depreciation & Amortization Expense - - - 14,088 41,309
Depreciation - - - 14,088 12,280
Amortization of Intangibles - - - 0 29,029
Gross Income - - - 100,866 88,918
2012 2013 5-year trend
SG&A Expense - - - 1.07M 3.58M
Research & Development - - - 0 0
Other SG&A - - - 1.07M 3.58M
Other Operating Expense - - - 0 0
Unusual Expense - - - 4.8M 1.38M
EBIT after Unusual Expense - - - (4.8M) (1.38M)
Non Operating Income/Expense - - - (1,322) 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) - - - - -
Interest Expense - - - 62,203 1.28M
Gross Interest Expense - - - 62,203 1.28M
Interest Capitalized - - - 0 0
Pretax Income - - - (5.84M) (6.15M)
Income Tax - - - 879 1,650
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - - - 0 -
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - - - (5.84M) (6.15M)
Minority Interest Expense - - - 0 0
Net Income - - - (5.84M) (6.15M)
Extraordinaries & Discontinued Operations - - - 0 0
Extra Items & Gain/Loss Sale Of Assets - - - 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations - - - 0 0
Net Income After Extraordinaries - - - (5.84M) (6.15M)
Preferred Dividends - - - 0 0
Net Income Available to Common - - - (5.84M) (6.15M)
EPS (Basic) - - - (0.08) (0.06)
Basic Shares Outstanding - - - 76.89M 99.04M
EPS (Diluted) - - - (0.08) (0.06)
Diluted Shares Outstanding - - - 76.89M 99.04M
EBITDA - - - (957,912) (3.45M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading